CClinicalTrials.gg
CompletedNCT04486066IMPROVEUpdated Jun 25, 2025Results posted

An Evaluation of MBSR and CBT for Veterans With Chronic Pain

An interventional study of Mindfulness-Based Stress Reduction and Cognitive Behavioral Therapy for Chronic Pain in Chronic Pain and Pain, sponsored by VA Office of Research and Development. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-06-25.

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
217
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Approximately fifty percent of Veterans report chronic pain. Management of chronic pain is often compounded by other life problems, including depression and posttraumatic stress disorder. Use of opioids for pain management entails risk of harm, and effective non-pharmacologic approaches to chronic pain management are needed. Mindfulness-Based Stress Reduction (MBSR) and group Cognitive Behavioral Therapy for Chronic Pain (CBT-CP) are programs that teach skills to improve functionality and quality of life for people with chronic pain. However, studies of MBSR and the group form of CBT-CP for chronic pain remain limited. In the proposed trial, MBSR will be compared to CBT-CP and usual care, with assessment of pain interference and other outcomes at 6-month follow-up. If MBSR and group CBT-CP are shown to be effective in improving outcomes, it would support use of these modalities for chronic pain.

Read the detailed description

Background: Pain is one of the most common reasons Veterans seek health care. Mental health conditions (including PTSD, anxiety, and depression) are estimated to co-occur for 30-50% of Veterans with chronic pain. Current recommendations for pain management include an integrative approach informed by the biopsychosocial model. It is increasingly recognized that use of opioids for pain management is associated with risk of harm, yet treatment studies of non-pharmacologic approaches remain limited. Mindfulness-Based Stress Reduction (MBSR) and Cognitive Behavioral Therapy for chronic pain (CBT-CP) teach skills intended to enhance functionality and quality of life in the face of chronic pain. The proposed randomized clinical trial will evaluate if MBSR and CBT-CP each result in improvements in pain interference that are superior to usual care. Two hundred twenty-two Veterans with chronic musculoskeletal pain will be randomized to MBSR, CBT-CP or usual care. Measures pertaining to the primary outcome of pain interference will be collected at baseline, at the post-MBSR/CBT-CP time point, and at 6-month follow-up. In addition, measures of pain intensity, depression, and treatment satisfaction will be applied to more fully characterize the impact of MBSR relative to CBT-CP and usual care. Exploratory analyses will assess if outcomes differ for MBSR and CBT-CP, the impact of the interventions on opioid use and indicators of suicidality, and whether Veteran characteristics assessed at baseline function as treatment moderators. Aims: Primary Aim: Assess if MBSR and CBT-CP each result in greater reductions in the pain interference subscale of the Brief Pain Inventory (BPI) as compared to usual care, from baseline to 6 months post-treatment. Secondary Aim: Evaluate if MBSR and CBT-CP are each superior to usual care in producing improvements in pain severity, treatment satisfaction, and depression. Exploratory Aim 1: Evaluate whether outcomes for patients randomized to MBSR and CBT-CP differ for changes in pain interference, pain severity, depression, and treatment satisfaction. Exploratory Aim 2: Evaluate the impact of MBSR and CBT-CP on utilization of opioid analgesics and markers of suicidality.

Exploratory Aim 3: Evaluate moderators of response to MBSR and CBT-CP to lay the groundwork for identifying Veterans more likely to succeed in one or the other treatment. Potential moderators assessed will include: age, gender, baseline depressive symptoms, anxiety sensitivity, and pain catastrophizing.

Design: A three-arm randomized controlled trial comparing MBSR, CBT-CP and usual care. Participants: 222 Veterans at a large urban VA facility with chronic musculoskeletal pain. Interventions: Group MBSR or group CBT-CP, each 8 weeks in duration. Analyses: Mixed models with assess whether MBSR, CBT-CP each produce greater reductions in outcome variables from baseline to follow-up compared to usual care. Implications: If MBSR and CBT-CP are each shown to be superior to usual care for treatment of chronic pain among Veterans, it would support providing MBSR and CBT-CP for this population.

02

Conditions studied

  • Chronic Pain
  • Pain

Keywords

  • mindfulness
  • cognitive behavioral therapy
03

In context

Chronic Pain

2,930 studies on the registry are indexed under Chronic Pain; 701 are open to participants now.

This study's enrollment of 217 is above the median of 60 across 2,161 interventional studies indexed under Chronic Pain.

Browse Chronic Pain studies →

Lead sponsor

VA Office of Research and Development is the lead sponsor of 1,733 studies on the registry; 396 are open to participants now.

Of its 206 completed or terminated interventional studies of FDA-regulated products, 180 (87%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

All participants must meet criteria for chronic musculoskeletal pain, defined as:

  • musculoskeletal pain of low back
  • cervical spine, or extremities (hip, knee, or shoulder)
  • pain for at least 3 months
  • pain severity (worst or average pain score equal to or greater than 4)(i.e., score of 4 or greater on BPI items 3 or 5) and average pain interference (BPI items 9A-9G) rated equal to or great than 3 of 10 over prior week, as measured using the Brief Pain Inventory (BPI)

Exclusion criteria

Exclusion Criteria:

At baseline, the MINI psychiatric interview will determine psychiatric exclusion criteria:

  • uncontrolled psychotic disorder
  • current bipolar affective disorder with mania
  • current suicidal or homicidal ideation with intent in the last month
  • inpatient psychiatric admission within the past month
  • severe medical conditions that would limit participation (e.g., Class III or IV heart failure)
  • pending back surgery

Additional exclusion criteria include prior formal participation in MBSR or CBT-CP. The investigators will include subjects with Alcohol Use Disorder (AUD; defined by the MINI) but exclude those for whom alcohol use poses a safety threat (defined as current drinking and a past-year history of alcohol-related seizures or delirium tremens). The investigators will also include those with Opioid Use Disorder (OUD) and other Substance Use Disorder (SUD; each defined by the MINI).

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
217 participants (actual)

Study arms

  • Experimental
    Mindfulness-Based Stress Reduction (MBSR)

    In MBSR, participants meet for 2 hours per week for 8 weeks in a video group format and receive instruction in mindfulness meditation according to a standardized curriculum, are given daily homework, participate in group discussions, and can ask questions.

    Behavioral: Mindfulness-Based Stress Reduction

  • Experimental
    Cognitive Behavioral Therapy for Chronic Pain (CBT-CP)

    Cognitive Behavioral Therapy (CBT) is the most widely used non-pharmacologic intervention for chronic pain and a version of CBT specifically addressing chronic pain (CBT-CP) has been developed for use in VA with Veterans. Fundamentally, CBT is an approach that seeks to ameliorate dysfunctional relationships between an individual's thoughts, feelings, and behaviors to improve functioning and quality of life. At our site, the CBT-CP format has been adapted for clinical use (i.e., as part of usual clinical care) to 8 sessions in a video group format, while retaining all essential elements.

    Behavioral: Cognitive Behavioral Therapy for Chronic Pain

  • Other
    Usual Care

    Veterans randomized to usual care will continue to be followed by their usual care providers for all medical and mental health care. This can include continued use of medications, specialty referrals and other usual elements of care. They will be asked to not enroll in the specific MBSR or CBT-CP interventions during the 8-month study period, but can attend other groups interventions, such as CBT-Insomnia, Acceptance and Commitment Therapy for Chronic Pain, and other groups for chronic pain and PTSD as directed by their treating providers. They can also enroll in MBSR or CBT-CP at the completion of the study.

    Other: Usual Care

Interventions

  • BehavioralMindfulness-Based Stress Reduction

    In MBSR, participants meet by video for 2 hours per week for 8 weeks in a group format and receive instruction in mindfulness meditation according to a standardized curriculum, are given daily homework, participate in group discussions, and can ask questions.

  • BehavioralCognitive Behavioral Therapy for Chronic Pain

    Cognitive Behavioral Therapy (CBT) is the most widely used non-pharmacologic intervention for chronic pain and a version of CBT specifically addressing chronic pain (CBT-CP) has been developed for use in VA with Veterans. Fundamentally, CBT is an approach that seeks to ameliorate dysfunctional relationships between an individual's thoughts, feelings, and behaviors to improve functioning and quality of life. At our site, the CBT-CP format has been adapted for clinical use (i.e., as part of usual clinical care) to 8 video sessions in a group format, while retaining all essential elements.

  • OtherUsual Care

    Veterans randomized to usual care will continue to be followed by their usual care providers for all medical and mental health care. This can include continued use of medications, specialty referrals and other usual elements of care. They will be asked to not enroll in the specific MBSR or CBT-CP interventions during the 8-month study period, but can attend other groups interventions, such as CBT-Insomnia, Acceptance and Commitment Therapy for Chronic Pain, and other groups for chronic pain and PTSD as directed by their treating providers. They can also enroll in MBSR or CBT-CP at the completion of the study.

06

What researchers measure

Primary outcomes

  1. Pain Interference Subscale of Brief Pain Inventory (BPI)

    The primary outcome is the Brief Pain Inventory Short Form Interference subscale (BPI). This is a 7-item scale that assesses the extent to which pain interferes with activities in daily life, such as general activity, mood, walking ability, work, relations with other people, sleep, and enjoyment of life. Scores range from 0 to 10 with higher scores indicating greater pain interference.

    Time frame: Baseline, Immediate post-treatment, 6 months after completing treatment

07

Results

Posted Jun 25, 2025

Participant flow

Participant flow — Overall Study
MilestoneMindfulness-Based Stress Reduction (MBSR)Cognitive Behavioral Therapy for Chronic Pain (CBT-CP)Usual Care
Started757171
Completed treatment48550
Post-treatment assessment686870
Completed666569
Not completed962

Outcome measures

PrimaryPain Interference Subscale of Brief Pain Inventory (BPI)

The primary outcome is the Brief Pain Inventory Short Form Interference subscale (BPI). This is a 7-item scale that assesses the extent to which pain interferes with activities in daily life, such as general activity, mood, walking ability, work, relations with other people, sleep, and enjoyment of life. Scores range from 0 to 10 with higher scores indicating greater pain interference.

Time frame:
Baseline, Immediate post-treatment, 6 months after completing treatment
Reported as:
Mean · score on a scale
Pain Interference Subscale of Brief Pain Inventory (BPI)
score on a scaleMindfulness-Based Stress Reduction (MBSR)Cognitive Behavioral Therapy for Chronic Pain (CBT-CP)Usual Care
Baseline4.7 ± 2.24.8 ± 2.24.9 ± 2.2
Post-treatment4.4 ± 2.33.7 ± 2.04.8 ± 2.2
6-month follow-up4.4 ± 2.63.8 ± 2.24.9 ± 2.5

Adverse events

Collected over 9 months (baseline to 6-months post-treatment assessment). Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Mindfulness-Based Stress Reduction (MBSR)0/75 (0%)1/75 (1.3%)0/75 (0%)
Cognitive Behavioral Therapy for Chronic Pain (CBT-CP)0/71 (0%)1/71 (1.4%)0/71 (0%)
Usual Care0/71 (0%)0/71 (0%)0/71 (0%)
Most frequent serious events
Most frequent serious events
EventMindfulness-Based Stress Reduction (MBSR)Cognitive Behavioral Therapy for Chronic Pain (CBT-CP)Usual Care
Hospitalization (not study related)Infections and infestations0/751/710/71
Hospitalization (not study related)Cardiac disorders1/750/710/71

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Mindfulness-Based Stress Reduction (MBSR)Cognitive Behavioral Therapy for Chronic Pain (CBT-CP)Usual CareTotal
<=18 years0000
Between 18 and 65 years383840116
>=65 years373331101
Age, Continuous
Age, Continuous(years)Mindfulness-Based Stress Reduction (MBSR)Cognitive Behavioral Therapy for Chronic Pain (CBT-CP)Usual CareTotal
Mean61.3 ± 14.960.8 ± 13.961.0 ± 12.661.0 ± 13.8
Sex: Female, Male
Sex: Female, Male(Participants)Mindfulness-Based Stress Reduction (MBSR)Cognitive Behavioral Therapy for Chronic Pain (CBT-CP)Usual CareTotal
Female15121340
Male605958177
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Mindfulness-Based Stress Reduction (MBSR)Cognitive Behavioral Therapy for Chronic Pain (CBT-CP)Usual CareTotal
Hispanic or Latino311418
Not Hispanic or Latino715967197
Unknown or Not Reported1102
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Mindfulness-Based Stress Reduction (MBSR)Cognitive Behavioral Therapy for Chronic Pain (CBT-CP)Usual CareTotal
American Indian or Alaska Native41510
Asian3148
Native Hawaiian or Other Pacific Islander0011
Black or African American15131341
White485044142
More than one race0000
Unknown or Not Reported56415
08

Study locations

1 site
  • VA Puget Sound Health Care System Seattle Division, Seattle, WA
    Seattle, Washington 98108-1532, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Oct 4, 2023
  • Informed consent form · Oct 4, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 25, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04486066
Lead sponsor
VA Office of Research and Development
Responsible party
Sponsor
First posted
Jul 24, 2020
Start date
Jan 27, 2021
Primary completion
May 1, 2024
Completion
Sep 30, 2024
Results posted
Jun 25, 2025
Last update
Jun 25, 2025

Study contacts

Tracy L Simpson, PhD
principal investigator · VA Puget Sound Health Care System Seattle Division, Seattle, WA

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion